Hudson Bay Capital Management LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $1.13 Million - $1.39 Million	-64,000 Reduced 29.77%	151,000 $2.98 Million
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $1.26 Million - $1.67 Million	-87,500 Reduced 28.93%	215,000 $3.77 Million
Q3 2023 Nov 14, 2023	SELL	$13.62 - $20.2 $5.14 Million - $7.63 Million	-377,500 Reduced 55.51%	302,500 $5.25 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $1.88 Million - $2.97 Million	-180,200 Reduced 20.95%	680,000 $9.57 Million
Q1 2023 May 16, 2023	BUY	$10.7 - $15.79 $2.61 Million - $3.85 Million	243,509 Added 39.49%	860,200 $9.26 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $178,593 - $263,550	16,691 Added 2.78%	616,691 $6.64 Million
Q4 2022 Feb 14, 2023	SELL	$11.42 - $17.05 $6.85 Million - $10.2 Million	-600,000 Reduced 50.0%	600,000 $8.99 Million
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $1.71 Million - $2.35 Million	-175,000 Reduced 12.73%	1,200,000 $15.4 Million
Q2 2022 Aug 12, 2022	BUY	$7.6 - $11.41 $722,000 - $1.08 Million	95,000 Added 7.42%	1,375,000 $13.3 Million
Q1 2022 May 16, 2022	BUY	$9.3 - $12.37 $2.14 Million - $2.85 Million	230,000 Added 21.9%	1,280,000 $12.7 Million
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $1.04 Million - $1.52 Million	-100,000 Reduced 8.7%	1,050,000 $12.4 Million
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $3.99 Million - $5.68 Million	350,000 Added 43.75%	1,150,000 $13.1 Million
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $4.03 Million - $5.82 Million	305,000 Added 61.62%	800,000 $11.1 Million
Q1 2021 May 14, 2021	SELL	$16.68 - $23.97 $1.75 Million - $2.52 Million	-105,000 Reduced 17.5%	495,000 $9.16 Million
Q4 2020 Feb 12, 2021	BUY	$14.8 - $21.15 $2.22 Million - $3.17 Million	150,000 Added 33.33%	600,000 $10.6 Million
Q3 2020 Nov 12, 2020	BUY	$15.21 - $25.53 $4.03 Million - $6.77 Million	265,000 Added 143.24%	450,000 $6.89 Million
Q2 2020 Aug 12, 2020	SELL	$15.08 - $26.0 $678,600 - $1.17 Million	-45,000 Reduced 19.57%	185,000 $4.71 Million
Q1 2020 May 14, 2020	SELL	$11.0 - $19.76 $2.31 Million - $4.15 Million	-210,000 Reduced 47.73%	230,000 $3.56 Million
Q4 2019 Feb 12, 2020	BUY	$5.24 - $12.96 $1.62 Million - $4.02 Million	310,000 Added 238.46%	440,000 $4.87 Million
Q3 2019 Nov 13, 2019	BUY	$8.15 - $15.88 $122,250 - $238,200	15,000 Added 13.04%	130,000 $1.11 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $330,000 - $509,750	25,000 Added 27.78%	115,000 $1.56 Million
Q1 2019 May 15, 2019	BUY	$15.93 - $26.59 $1.43 Million - $2.39 Million	90,000 New	90,000 $1.63 Million

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$33.1 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.42 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.13 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$860,794
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$654,000
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account